| My Account | Subscribe | Contact Us | Donate |
Home
- The Edmonton Protocol and Me
- Olympia Dukakis and Her Husband Tackle Type 2
- Surfing with Type 1
- Behind the Wheel, But Still in Control
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Related Monitoring Threads on Diabetes Health Forums
When I was a child, my mother always said, "Think before you speak." Have you heard of this before? If not, please digest my words. If you have heard of this simple yet beneficial policy, please reconsider its merit and then implement it into your practice.
0 comments - Nov 7, 2009 -
The American Association of Clinical Endocrinologists (AACE) and the College of Endocrinology (ACE) released online a one-page resource for physicians and healthcare providers for the management of glycemic control in type 2 diabetes.
0 comments - Nov 7, 2009 -
MINNEAPOLIS--(BUSINESS WIRE)--Employers are signing up for a first-of-its-kind health plan by UnitedHealthcare designed to help control the escalating costs of insuring diabetic and pre-diabetic employees and their families while improving their health.
0 comments - Nov 7, 2009 -
I recently ran into Theresa Garnero at the California AADE annual meeting and discovered that Diabetes Health had not yet reviewed her book, Your First Year with Diabetes: What To Do, Month By Month. We regret the oversight because it's a great resource for anyone dealing with the shock of a diabetes diagnosis. And Garnero is the perfect author for a book like this. She's an award-winning certified diabetes educator (CDE) and advanced practice registered nurse (APRN) with board certification in advanced diabetes management (BC-ADM), and she earned an Master of Science in Nursing (MSN). She is also a former national educator of the year, a cartoonist, and the 2008 global recipient of Inspired by Diabetes.
0 comments - Nov 6, 2009 -
Fingertip blood-oxygen monitors, called pulse oximeters, measure oxygen in the blood using light and color. The noninvasive device, which clips onto a fingertip or earlobe, typically has a pair of light-emitting diodes (LEDs) facing a sensor. Light of a certain wavelength (a certain color) travels through a translucent part of the body like the fingertip or an earlobe, and is picked up by the sensor. The amount of oxygen in the blood (actually, oxygenated hemoglobin) affects how much light from each diode finally makes it through the finger and reaches the sensor. The result is an effective measurement of the amount of oxygen in the blood.
3 comments - Nov 5, 2009 -
If you bought Vytorin® and/or Zetia® to lower your cholesterol between November 1, 2002, and September 17, 2009, you may be entitled to some money. A lawsuit against Merck & Co., Inc., Schering-Plough Corporation, Merck/Schering-Plough Pharmaceuticals, and other defendants has reached a proposed settlement in the United States District Court for the District of New Jersey. The lawsuit, according to vytorinzetiasettlement.com (the authorized website for the settlement), claims that Vytorin and Zetia "were marketed as being more effective than other anti-cholesterol drugs and were sold at higher prices, when they were no more effective than less expensive anti-cholesterol drugs". The defendants, according to the website, "deny any wrongdoing and are settling this lawsuit to avoid the costs and expenses of further litigation."
0 comments - Nov 5, 2009 -
Congress is getting a little bit closer to making the changes to the health care system we've been dreaming about for a very long time. The American Diabetes Association (ADA) says these changes could provide a real benefit to people with diabetes. Draft health care reform bills have now passed through the committee process in both the House and the Senate.
7 comments - Nov 4, 2009 -
Professor Peter Schwartz, MD, is a very busy man in the European diabetes community. He's a professor of medicine, a scientist, and a medical doctor in the Division of Prevention and Care of Diabetes, Department of Medicine, University of Dresden. It's a mystery how he finds enough hours in the day to do what he does. Diabetes Health recently interviewed him via email since he lives and works in Dresden, Germany.
0 comments - Nov 3, 2009 -
The California Association of American Diabetes Educators held its second annual meeting October 22 through 24, 2009, in Monterey, California, and Diabetes Health was there. The clinical and educational program, put together by Debra Norman and Kim Higgins, was called "Tidal Wave of Diabetes." The invited speakers shared innovation, research, and new techniques with the attendees.
0 comments - Nov 3, 2009 -
Novocell is the Recipient of a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
San Diego, CA (October 28, 2009) - Novocell, Inc., a preclinical stage diabetes company, today announced that it will receive a Disease Team award totaling $20 million from the California Institute for Regenerative Medicine (CIRM). The Disease Team includes a group of scientists at the University of California, San Francisco (UCSF), led by Dr. Jeff Bluestone, which is contracted to receive $2.8 million. The funding will advance Novocell's development of a first in kind cellular therapy for the treatment of diabetes.
0 comments - Oct 31, 2009 -
